Catiuscia Molz de Freitas Selected Research

Motor Disorders

11/2017

Resveratrol Protects Against Vacuous Chewing Movements Induced by Chronic Treatment with Fluphenazine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catiuscia Molz de Freitas Research Topics

Disease

5	Tardive Dyskinesia 01/2018 - 10/2014
4	Dyskinesias (Dyskinesia) 12/2020 - 10/2014
2	Schizophrenia (Dementia Praecox) 11/2017 - 01/2016
1	Brain Diseases (Brain Disorder) 04/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2019
1	Motor Disorders 11/2017
1	Body Weight (Weight, Body) 11/2017
1	Parkinson Disease (Parkinson's Disease) 02/2016
1	Nervous System Diseases (Neurological Disorders) 02/2016
1	Movement Disorders (Movement Disorder) 10/2014

Drug/Important Bio-Agent (IBA)

3	Antipsychotic Agents (Antipsychotics)IBA 01/2018 - 10/2014
2	Reserpine (Serpasil)FDA Link 12/2020 - 02/2016
2	Monoamine Oxidase (MAO)IBA 04/2019 - 11/2017
2	Fluphenazine (Prolixin)FDA LinkGeneric 11/2017 - 05/2016
1	Catechin (Z 7300)IBA 12/2020
1	IsoflavonesIBA 04/2019
1	AntioxidantsIBA 04/2019
1	ResveratrolIBA 11/2017
1	Biomarkers (Surrogate Marker)IBA 05/2016
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 02/2016
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2016
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2016
1	Haloperidol (Haldol)FDA LinkGeneric 10/2014
1	EndocannabinoidsIBA 10/2014
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2014
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 10/2014
1	CannabinoidsIBA 10/2014